Virtual Medicinal Product (VMP) - Amphotericin B (lipid formulation) 100mg powder for solution for infusion vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Amphotericin B (lipid formulation) 100mg powder for solution for infusion vials Start Date 13-01-2009 End Date
Previous Name Previous Name Amphotericin B (lipid formulation) 100mg powder for solution for injection vials Start Date 11-10-2007 End Date 12-01-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Invalid
Prescribing Status
Caution - AMP level prescribing advised
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Powder for solution for infusion
Ontology Form/Route
solutioninfusion.intravenous
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
J02AA01
BNF Start Date End Date
Previous BNF 05020000 Start Date 22-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
8062011000001106 06-09-2004

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Amphotericin B Based on Ingredient Substance 100 mg

Parent Products

  • VTM
    No Parent VTM
    • VMP
      (Current) Amphotericin B (lipid formulation) 1...
      • AMP
        No AMP's

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial